UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone
PHASE2
This is a Phase 2 Study of Everolimus and Lenvatinib in patients with metas...
Status
Suspended
Location
Abramson Cancer Center of the University of Pennsylvania
A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease
PHASE2
This is a single-arm, multicenter, Phase 2 study of lenvatinib in combinati...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment
PHASE1
This is an open-label, multicenter, Phase 1b/2 study of lenvatinib alone an...